SCMP Financial Facts
Basic net income (loss) per share: 0.19Total non-operating income (expense), net: 2.23M
See Full Income Statement
Notes payable, non-current: 196.98M
Common stock: 458K
See Full Balance Sheet
Sucampo Pharmaceuticals (SCMP) Earnings
|
Expand Research on SCMP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/11  |
 |
Q410 | -$0.15 | -$0.01 | -$0.14 | $12.4M | $15.5M | N/A |  | | Details |
| 11/9/16 |
|
Q316 | $0.28 | $0.26 | +$0.02 | $57.9M | $51.46M |  |
| | Details |
| 11/6/14 |
Q313 | $0.03 | $0.04 | -$0.01 | $31.5M | $26.11M | N/A | | | Details | |
| 3/4/15 |
|
Q413 | $0.21 | $0.18 | +$0.03 | $37.8M | $37.23M | = | | | Details |
| 3/13/13 |
|
Q412 | $0.32 | $0.12 | +$0.20 | $34.9M | $32.21M | N/A | | | Details |
| 8/5/15 |
|
Q215 | $0.21 | $0.15 | +$0.06 | $34.9M | $31.9M | = | | | Details |
| 8/5/14 |
|
Q213 | $0.04 | $0.03 | +$0.01 | $24.1M | $24.06M | N/A | | | Details |
| 8/3/16 |
|
Q216 | $0.23 | $0.22 | +$0.01 | $52M | $48.61M | |
| | Details |
